Neurovascular embolectomy device is used during an embolectomy procedure. These devices are used for removal of emboli, obstructing the blood circulation, surgically. Usually, embolectomy is the least preferred option for treatment and other involved therapeutic options are anticoagulation and thrombolysis. Neurovascular device market has undergone a demand-shift with respect to products and techniques. Doctors want to adopt instruments and techniques that offer higher window for stroke treatment with high success rate and minimal post-surgical impact. This is supported by the fact that demand for bare platinum coils is growing at a higher pace in comparison to coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum coils. Additionally, stroke treatment involves high healthcare expenditure that drives the focus on development of economical treatment techniques.

The global Neurovascular Embolectomy Device market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neurovascular Embolectomy Device volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neurovascular Embolectomy Device market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Boston Scientific Corporation
Cook Medical
DePuy Synthes
Edwards Lifesciences Corporation
iVascular SLU
LeMaitre Vascular, Inc
Medtronic
Straub Medical AG
Teleflex Inc

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Aspiration Systems
Stent Retreival Systems

Segment by Application
Hospital
Medical Center
Other